We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+17.13%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$31.9B
AUM Growth
+$4.19B
Cap. Flow
+$23.1M
Cap. Flow %
0.07%
Top 10 Hldgs %
18.87%
Holding
1,397
New
111
Increased
494
Reduced
445
Closed
146

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$83.9M
2
QDEL icon
QuidelOrtho
QDEL
+$75.7M
3
GXC icon
State Street SPDR S&P China ETF
GXC
+$73.7M
4
TSLA icon
Tesla
TSLA
+$58.1M
5
MSFT icon
Microsoft
MSFT
+$48.7M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$149M
2
HON icon
Honeywell
HON
+$72.2M
3
IBM icon
IBM
IBM
+$66M
4
INTC icon
Intel
INTC
+$63.3M
5
LMND icon
Lemonade
LMND
+$56M

Sector Composition

Rank Sector Weight
1 Technology 30.89%
2 Healthcare 17.61%
3 Consumer Discretionary 11.58%
4 Financials 10.48%
5 Industrials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STN icon
876
Stantec
STN
$8.17B
$1.58M 0.01%
+48,700
New +$1.49M
DOV icon
877
Dover
DOV
$26.7B
$1.58M 0.01%
12,496
+1,340
+12% +$159K
CTMX icon
878
CytomX Therapeutics
CTMX
$690M
$1.57M ﹤0.01%
239,650
+78,524
+49% +$561K
ARWR icon
879
Arrowhead Research
ARWR
$12.1B
$1.56M ﹤0.01%
20,400
EEFT icon
880
Euronet Worldwide
EEFT
$3.19B
$1.56M ﹤0.01%
+10,800
New +$1.26M
FXE icon
881
Invesco CurrencyShares Euro Currency Trust
FXE
$344M
$1.55M ﹤0.01%
13,493
DOC icon
882
Healthpeak Properties
DOC
$15.5B
$1.52M ﹤0.01%
50,390
+15,387
+44% +$448K
NBIX icon
883
Neurocrine Biosciences
NBIX
$18.2B
$1.52M ﹤0.01%
15,841
-54,215
-77% -$5.24M
HR
884
DELISTED
Healthcare Realty Trust Incorporated
HR
$1.52M ﹤0.01%
51,290
OXY icon
885
Occidental Petroleum
OXY
$55.7B
$1.51M ﹤0.01%
87,222
-55,847
-39% -$766K
MDU icon
886
MDU Resources
MDU
$4.18B
$1.51M ﹤0.01%
150,429
BZUN
887
Baozun
BZUN
$179M
$1.49M ﹤0.01%
43,500
+9,547
+28% +$350K
EQC
888
DELISTED
Equity Commonwealth
EQC
$1.49M ﹤0.01%
54,719
+17,500
+47% +$467K
CCK icon
889
Crown Holdings
CCK
$13B
$1.48M ﹤0.01%
14,800
-3,500
-19% -$322K
TPCO
890
DELISTED
Tribune Publishing Company Common Stock
TPCO
$1.47M ﹤0.01%
107,298
+8,800
+9% +$108K
TDS icon
891
Telephone and Data Systems
TDS
$3.87B
$1.44M ﹤0.01%
77,400
-89,000
-53% -$1.64M
OVID icon
892
Ovid Therapeutics
OVID
$427M
$1.43M ﹤0.01%
620,402
+25,735
+4% +$120K
SLB icon
893
SLB Ltd
SLB
$72.7B
$1.43M ﹤0.01%
65,643
-31,302
-32% -$591K
GPK icon
894
Graphic Packaging
GPK
$3.35B
$1.42M ﹤0.01%
84,000
MTRN icon
895
Materion
MTRN
$3.94B
$1.42M ﹤0.01%
22,200
-1,100
-5% -$63.3K
FCN icon
896
FTI Consulting
FCN
$5.14B
$1.41M ﹤0.01%
12,600
-24,700
-66% -$2.66M
LOPE icon
897
Grand Canyon Education
LOPE
$4.22B
$1.39M ﹤0.01%
14,900
DLR icon
898
Digital Realty Trust
DLR
$69.6B
$1.38M ﹤0.01%
9,851
-15,900
-62% -$2.27M
VYGR icon
899
Voyager Therapeutics
VYGR
$181M
$1.36M ﹤0.01%
189,700
-1,800
-0.9% -$17.3K
WK icon
900
Workiva
WK
$3.45B
$1.35M ﹤0.01%
14,700
-1,300
-8% -$91.3K

Similar funds

Axa's Q4 2020 Portfolio in Review

As of Q4 2020, Axa held 1,397 positions worth $31.9B, up 15% from $27.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Axa's Q4 2020 filing shows 111 new, 494 increased, 445 reduced and 146 closed positions. Its largest new stake was State Street SPDR S&P China ETF: 580,524 shares worth $75.6M. The largest sale was Linde, an estimated $149M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q4 2020 buy was State Street SPDR S&P China ETF: 580,524 shares worth $75.6M.
  • Axa added most to Amazon in Q4 2020, an estimated $83.9M increase.
  • Axa's biggest Q4 2020 reduction was Linde, cutting an estimated $149M.
  • Axa fully exited Jumia Technologies in Q4 2020, selling an estimated $42.2M.
  • Axa's ten largest holdings make up 19% of its $31.9B portfolio in Q4 2020.
  • Axa opened 111 new positions and closed 146 in Q4 2020.
  • Axa's portfolio value rose 15% quarter-over-quarter to $31.9B.

Based on Axa's 13F filing for Q4 2020, filed 12 Feb 2021.